Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Identification of New Biomarkers Useful to Define the Course of Multiple Sclerosis and Study of the Mechanisms That Promote Synaptic Damage
Authors not listed
Neuromed IRCCS · 2017
Abstract
A prospective and retrospective cohort study of about five years will be performed on blood and cerebrospinal fluid samples taken for diagnostic reasons from recruited patients within the Neuromed Neurology Unit. Subjects with other chronic neurodegenerative diseases such as Amyotrophic lateral sclerosis (ALS), Alzheimer's disease (AD) and Parkinson's disease (PD), and healthy subjects subjected to blood sampling and / or lumbar puncture for clinical reasons will be recruited As control groups.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-11-07 MST
Cite this
APA
Anonymous. (2017). Identification of New Biomarkers Useful to Define the Course of Multiple Sclerosis and Study of the Mechanisms That Promote Synaptic Damage. <em>Neuromed IRCCS</em>. https://clinicaltrials.gov/study/NCT03217396
Vancouver
Anonymous. Identification of New Biomarkers Useful to Define the Course of Multiple Sclerosis and Study of the Mechanisms That Promote Synaptic Damage. Neuromed IRCCS. 2017.
BibTeX
@misc{anon2017Identi,
title = {Identification of New Biomarkers Useful to Define the Course of Multiple Sclerosis and Study of the Mechanisms That Promote Synaptic Damage},
author = {Anonymous},
journal = {Neuromed IRCCS},
year = {2017},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
International journal of molecular sciences 2026
Open access · OA
Proteasome Dysfunction and Aggregation-Prone Proteins in Neurodegenerative Diseases: From Mechanisms to Therapeutic Opportunities.
International Journal of Molecular Sciences 2026
Open access · CC-BY
Proteasome Dysfunction and Aggregation-Prone Proteins in Neurodegenerative Diseases: From Mechanisms to Therapeutic Opportunities
University Hospital, Strasbourg, France 2012
Open access · US-GOV
Evaluation of fMRI-SAM in the Early Detection of Alzheimer's Disease.
Frontiers in Genetics 2021
Open access · CC-BY
Advances in mt-tRNA Mutation-Caused Mitochondrial Disease Modeling: Patients’ Brain in a Dish
Vanderbilt University Medical Center 2026
Open access · US-GOV
Cholinergic Deep Brain Stimulation for Alzheimer's Disease
Essays in Biochemistry 2020
Open access · CC-BY